NLRP3 and Hepatic fibrosis: Notably, we found that VDR activation can induce YAP1 expression at the transcriptional level in liver tissue and HSC line and increased YAP1 further exerts its inhibitory effect on NLRP3 expression to alleviate cholestatic liver fibrosis and injury.